| Literature DB >> 33946416 |
Yung-Li Wang1, Cai-Mei Zheng2,3,4, Yu-Hsuan Lee5, Ya-Yun Cheng6, Yuh-Feng Lin1,2,3, Hui-Wen Chiu1,3,7.
Abstract
With rapid industrialization, humans produce an increasing number of products. The composition of these products is usually decomposed. However, some substances are not easily broken down and gradually become environmental pollutants. In addition, these substances may cause bioaccumulation, since the substances can be fragmented into micro- and nanoparticles. These particles or their interactions with other toxic matter circulate in humans via the food chain or air. Whether these micro- and nanoparticles interfere with extracellular vesicles (EVs) due to their similar sizes is unclear. Micro- and nanoparticles (MSs and NSs) induce several cell responses and are engulfed by cells depending on their size, for example, particulate matter with a diameter ≤2.5 μm (PM2.5). Autophagy is a mechanism by which pathogens are destroyed in cells. Some artificial materials are not easily decomposed in organisms. How do these cells or tissues respond? In addition, autophagy operates through two pathways (increasing cell death or cell survival) in tumorigenesis. Many MSs and NSs have been found that induce autophagy in various cells and tissues. As a result, this review focuses on how these particles interfere with cells and tissues. Here, we review MSs, NSs, and PM2.5, which result in different autophagy-related responses in various tissues or cells.Entities:
Keywords: autophagy; extracellular vesicles; microparticles; nanoparticles
Mesh:
Substances:
Year: 2021 PMID: 33946416 PMCID: PMC8124422 DOI: 10.3390/ijms22094787
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Schematic picture of several major endocytosis pathways for micro- and nanosized substances (MSs and NSs). MSs and NSs employ one or multiple endocytosis pathways to enter cells. The main endocytosis pathways of MSs or NSs include clathrin-mediated endocytosis, caveolae/lipid raft-mediated endocytosis, clathrin- and caveolin-independent endocytosis, macropinocytosis and phagocytosis. The possible mechanisms by which MSs and NSs modulate several cell responses, such as ER-stress, mitochondrial damage, lysosome dysfunction, ROS production, and autophagy, are summarized. MSs: Micro-sized substances; NSs: Nanosized substances.
Figure 2Schematic picture of the macroautophagy process. MNs and NSs, including protein aggregates, damaged organs, plastics particles, dust, and silica are shown. LC3-II, Beclin 1, and p62 conjugate enzymes generate the phagophore form and then the surrounding MNs and NSs during the elongation stage. At the end of the elongation stage, the membrane is sealed to form a double-membrane vesicle, called the autophagosome, which contains degraded cellular enzymes. The autophagosome fuses with a lysosome, forming an autolysosome in which lysosomal enzymes degrade the cargo and release the degraded products into the cytoplasm. Undecomposed MSs and NSs, such as dust and silica, have carcinogenic potential.
Figure 3Schematic picture of undecomposed MSs and NSs causing diseases. MSs and NSs can cause obstruction, inflammation, and accumulation in organs. MSs and NSs, such as dust, silica, asbestos, plastics MSs, and PM2.5, have been found to be related to diseases in previous studies.
MSs & NSs of autophagy-related responses in cells or tissues.
| MSs & NSs | Autophagy-Related Responses | Cells or Tissues | Reference |
|---|---|---|---|
| Magnetic nanoparticles | Autophagy markers: Atg5, Atg12, and LC3 | In vitro: Human lung adenocarcinoma cells | [ |
| Manganese nanoparticles | Autophagy markers: Beclin 1, and LC3 | In vitro: Rat mesencephalic dopaminergic cells | [ |
| Quantum dots | Autophagy markers: p62 and LC3 | In vitro: Rat adrenal medulla | [ |
| Autophagy marker: LC3 | In vitro: Porcine renal proximal cell line | [ | |
| Graphene oxide quantum dots | Autophagy markers: p62 and LC3 | In vitro: Mouse reproductive cells | [ |
| Graphene oxide | Autophagy markers: p62 and LC3 | In vitro: Rat glioblastoma cells | [ |
| Particulate matter 2.5 | Autophagy markers: Beclin 1, ULK-1, and LC3 | In vitro: Human bronchial epithelial cells (BEAS-2B) | [ |
| Autophagy markers: Beclin 1, ATG5,ULK-1, and LC3 | In vitro: Monocytic leukemia cells (THP-1) | [ | |
| Autophagy-mediated cell death | In vitro: Human bronchial epithelium cells | [ | |
| Autophagy markers: p62 and LC3 | In vivo: Liver of C57BL/6 mice | [ | |
| Autophagy markers: ATG5, VSP34, Beclin 1, and LC3 | In vivo: Spleen of Sprague Dawley (SD) rats | [ | |
| Autophagy markers: p62, Beclin 1, and LC3 | In vitro: Human kidney tubular epithelial cells | [ | |
| In vivo: Kidney of SD rat | |||
| Diesel exhaust particles (DEP) | Autophagy markers: p62, Beclin 1, and LC3 | In vitro: Human kidney tubular epithelial cells (HK-2) | [ |
| In vivo: Kidney of SD rat | |||
| Zinc oxide (ZnO) | Autophagy markers: p62 and LC3 | In vitro: Human cervical cancer cells (HeLa cells) | [ |
| Autophagy marker: LC3 | [ | ||
| Autophagy marker: LC3 | In vitro: Human ovarian cancer cells (SKOV3) | [ | |
| Autophagy markers: p62 and LC3 | In vitro: Human epidermal keratinocytes (HEKn) | [ | |
| Autophagy marker LC3A | In vitro: Human T lymphoblast cells (SupT1 and Jurkat cells), C57BL/6 mouse primary splenocytes and primary human T-cells | [ | |
| Autophagic cell death | In vitro: Rat adrenal medulla | [ | |
| Autophagy marker: LC3 | In vitro: Primary murine astrocytes | [ | |
| Silica nanoparticles | Autophagy marker: LC3 | In vitro: Human liver cancer cells (HepG2 cells) | [ |
| Autophagy marker: P62 | In vitro: Human bronchial epithelial cells | [ | |
| In vivo: Lung of Bltw:CD1 (ICR) mice | |||
| Autophagy markers: p62 and LC3 | Human umbilical vein endothelial cells (HUVECs) | [ | |
| Silver nanoparticles | Autophagy markers: LC3 | In vitro: Human liver cancer cells (HepG2 cells) | [ |
| Autophagy markers: p62 and LC3 | In vitro: Human lung adenocarcinoma cells | [ | |
| Autophagy markers: Beclin 1 and LC3 | In vivo: Adult brain of Wistar rat | [ | |
| Autophagy markers: P62 and LC3 | In vitro: Mouse embryonic fibroblast cells | [ | |
| Bismuth nanoparticles | Autophagy markers: Atg12, Beclin 1, and LC3 | In vitro: Human embryonic kidney 293 cells (HEK293) | [ |
| In vivo: Kidney of BALB/c mice | |||
| Autophagy marker: p62 | In vitro: Human liver cancer cells (HepG2 cells) | [ | |
| Autophagy associated cytotoxicity | In vitro: Human embryonic kidney 293 cells (HEK293) | [ | |
| Nanosized titanium dioxide(Nano TiO2) | Autophagy markers: Beclin 1, p62, and LC3 | In vitro: Mouse podocyte cells (MPCs) | [ |
| Autophagy marker: LC3 | In vitro: Human keratinocytes (HaCaT cells) | [ | |
| Autophagy marker: LC3 | In vitro: Human cervical cancer cells (HeLa cells) | [ | |
| Autophagy markers: p62, LC3 | In vitro: Human trophoblast cells | [ | |
| Copper oxide nanoparticles | Autophagic cell death | In vitro: Human lung adenocarcinoma cells | [ |
| Polystyrene (PS) nanoplastics | Endoplasmic Reticulum(ER) stress-mediated | In vitro: Human bronchial epithelial cells | [ |
| Autophagic marker: LC3B | In vitro: Mouse embryonic fibroblasts (MEFs) | [ | |
| Autophagy markers: p62, Beclin 1, and LC3 | In vitro: Mouse macrophage-like cells (RAW 264.7) and human bronchial epithelial cells (BEAS-2B) | [ | |
| Vinyl chloride (VC) | Autophagy markers: Beclin 1 and LC3 | In vitro: Human kidney tubular epithelial cells (HK-2) | [ |
| In vivo: Kidney of C57BL/6 mice | |||
| Asbestos | Autophagy markers: ATG5, p62, | In vitro: Primary human mesothelial cells (HM) | [ |